申万菱信中证申万医药生物指数A(163118)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/9/30 |
336,873,000 |
337,894,000 |
16,015,600 |
14,994,400 |
1,021,200 |
0.3% |
2024/6/30 |
328,722,000 |
336,873,000 |
47,887,000 |
39,736,000 |
8,151,000 |
2.48% |
2024/6/30 |
336,921,000 |
336,873,000 |
13,492,400 |
13,540,700 |
-48,300 |
-0.01% |
2024/3/31 |
328,722,000 |
336,921,000 |
34,394,500 |
26,195,300 |
8,199,200 |
2.49% |
2023/12/31 |
338,516,000 |
328,722,000 |
90,399,900 |
100,195,000 |
-9,795,100 |
-2.89% |
2023/12/31 |
331,604,000 |
328,722,000 |
14,635,600 |
17,517,600 |
-2,882,000 |
-0.87% |
2023/9/30 |
327,786,000 |
331,604,000 |
23,755,300 |
19,938,200 |
3,817,100 |
1.16% |
2023/6/30 |
338,516,000 |
327,786,000 |
52,008,900 |
62,739,000 |
-10,730,100 |
-3.17% |
2023/6/30 |
326,109,000 |
327,786,000 |
22,326,800 |
20,649,100 |
1,677,700 |
0.51% |
2023/3/31 |
338,516,000 |
326,109,000 |
29,682,100 |
42,089,800 |
-12,407,700 |
-3.67% |
2022/12/31 |
279,235,000 |
338,516,000 |
197,513,000 |
138,232,000 |
59,281,000 |
21.23% |
2022/12/31 |
332,550,000 |
338,516,000 |
48,494,800 |
42,527,900 |
5,966,900 |
1.79% |
2022/9/30 |
311,878,000 |
332,550,000 |
51,114,500 |
30,442,500 |
20,672,000 |
6.63% |
2022/6/30 |
279,235,000 |
311,878,000 |
97,903,400 |
65,261,200 |
32,642,200 |
11.69% |
2022/6/30 |
303,517,000 |
311,878,000 |
37,075,700 |
28,715,000 |
8,360,700 |
2.75% |
2022/3/31 |
279,235,000 |
303,517,000 |
60,827,700 |
36,546,200 |
24,281,500 |
8.7% |
2021/12/31 |
316,139,000 |
279,235,000 |
210,257,000 |
247,160,000 |
-36,903,000 |
-11.67% |
2021/12/31 |
265,329,000 |
279,235,000 |
40,150,900 |
26,244,300 |
13,906,600 |
5.24% |
2021/9/30 |
259,791,000 |
265,329,000 |
57,795,900 |
52,257,700 |
5,538,200 |
2.13% |
2021/6/30 |
316,139,000 |
259,791,000 |
112,311,000 |
168,658,000 |
-56,347,000 |
-17.82% |
2021/6/30 |
284,928,000 |
259,791,000 |
24,426,600 |
49,563,800 |
-25,137,200 |
-8.82% |
2021/3/31 |
316,139,000 |
284,928,000 |
87,884,000 |
119,095,000 |
-31,211,000 |
-9.87% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。